First Choice Neurology

First Choice Neurology Research Center 32 Clinical Trials

First Choice Neurology Research Center 32 offers clinical trials for Migraines, Alzheimer’s disease, Hypotension, Multiple Sclerosis, Parkinson’s disease, Epilepsy, and other neurological disorders.

clinical trials

Interventional:

ALITHIOS by Novartis

This is a 5-year clinical trial, investigating the long-term safety and tolerability of Ofatumumab in patients with Relapsing Multiple Sclerosis. Patients must have participated in a Novartis MS trial using Ofatumumab as ALITHIOS is an open-label extension trial to its predecessor.

Celgene

A 3 year, an open-label trial investigating cognitive processing speed changes in subjects with relapsing multiple sclerosis treated with Ozanimod.

EMD Serono

A 2-3.5 year trial, investigating the safety and efficacy of Evobrutinib compared to Teriflunomide.

Novartis

A 6 month, open-label trial, investigating safety and tolerability of conversion from oral or injectable disease-modifying therapies to oral Siponimod in patients with advancing forms of relapsing multiple sclerosis.

 

Observational:

Eli Lilly

A 2-year trial, investigating the real-world effectiveness and associated outcomes in patients with migraine during routine clinical care.

 


Contact First Choice Neurology Research Center 32

Neurology Office of South Florida, LLC
9970 Central Park Blvd., Suite 207
Boca Raton, FL 33428
Phone: (561) 482-1027
Fax: (561) 482-1028

Providers:
Brian Costell, MD
Meghan Jacobs, PsyD
Carol Eickhorn, ARNP

Contact:
Cody Paauwe, CRC
(561) 482-1027 ext. 9
cpaauwe@fcneurology.net

Translate »